Surely the answer from FDA is going to be yes!

My understanding is this Co has cash greater than sp...so the treatments and pipeline are "free" - - - there may have been a disapointment that caused this slide ( was it Oct 07 as mentioned here?) . . . . . I attended their AGM a few weeks ago - I've topped up since, at current levels, and it surprising how many you get for the money!
This may not be a 10-bagger, but I believe it's undervalued, based only on their cash if you must. Previously my holding was sold/already "written off" having only a small number as a rump to attend agm's, get Reports etc.
It's full-List, = ISA-able....=very tasty, if good. But don't spend too much. DYOR.